Profiel
Jörgen Persson worked as the Chief Executive Officer at Dunross & Co. AB from 2010 to 2013 and also worked at Cellectricon AB as a Director.
Eerdere bekende functies van Jörgen Persson
| Bedrijven | Functie | Einde |
|---|---|---|
Dunross & Co. AB
 Dunross & Co. AB Investment ManagersFinance Dunross & Co. AB (D&C) is a private placement firm located in Gothenburg, Sweden. D&C was established in 1989 as an independent firm owned and managed by their CEO and founder, Sven Norfeldt. | Algemeen Directeur | 01-08-2013 |
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Dunross & Co. AB
Dunross & Co. AB Investment ManagersFinance Dunross & Co. AB (D&C) is a private placement firm located in Gothenburg, Sweden. D&C was established in 1989 as an independent firm owned and managed by their CEO and founder, Sven Norfeldt. | Finance |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
